A detailed history of Ameriprise Financial Inc transactions in Mannkind Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 17,805 shares of MNKD stock, worth $108,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,805
Holding current value
$108,432
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $89,203 - $119,293
17,805 New
17,805 $111,000
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $138,854 - $184,110
-34,285 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.61 - $5.45 $123,768 - $186,853
34,285 New
34,285 $187,000
Q3 2020

Nov 16, 2020

SELL
$1.56 - $2.08 $72,479 - $96,638
-46,461 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$0.94 - $2.21 $1,880 - $4,420
2,000 Added 4.5%
46,461 $82,000
Q1 2020

May 15, 2020

BUY
$0.84 - $1.76 $37,347 - $78,251
44,461 New
44,461 $46,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.